Silence Therapeutics plc — Form D
Silence Therapeutics plc of LONDON, X0, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-18. The offering totals $45.5M, of which $45.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-02-18
- Form: D
- Accession: 0001231919-21-000018
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $45.5M
- Amount sold: $45.5M
- Investors: 12
- Date of first sale: 2021-02-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-389800
Issuer
- Name: Silence Therapeutics plc
- CIK: 0001479615
- Entity type: Corporation
- Jurisdiction: UNITED KINGDOM
- Address: 72 HAMMERSMITH ROAD, LONDON, X0, W14 8TH
- Phone: 44-0-20-3457 6900
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Michael H Davidson | Director | London, X0 |
| James Ede-Golightly | Director | London, X0 |
| Alistair Gray | Director | London, X0 |
| Dave Lemus | Director | London, X0 |
| Iain Ross | Director | London, X0 |
| Mark Rothera | Director | London, X0 |
| Romano Steven | Director | London, X0 |
| Giles Campion | Executive Officer | London, X0 |
| Mark Rothera | Executive Officer | London, X0 |
| Barbara Ruskin | Executive Officer | London, X0 |
| Craig Tooman | Executive Officer | London, X0 |
| Iain Ross | Executive Officer | London, X0 |
| Jeremy Curnock Cook | Director | Montreal, A8 |
| Melvyn Curnock Davies | Director | London, X0 |
| Melvyn Curnock Davies | Executive Officer | London, X0 |
| Annette Clancy | Director | London, X0 |
| Peter Curnock Reynolds | Director | London, X0 |
| David Curnock U'Prichard | Director | London, X0 |
| Jerry Curnock Randall | Director | London, X0 |
| Bernd Curnock Wetzel | Director | London, X0 |
Other filings by this issuer (3)
More